Contact PI/Project LeaderPIERCE, ROBERT CHRISTOPHER
Awardee OrganizationRUTGERS BIOMEDICAL AND HEALTH SCIENCES
Description
Abstract Text
Project Summary/Abstract
The over-arching goal of the current program is to unify the training in substance use disorder research at
Rutgers Piscataway/New Brunswick encompassing the existing strengths in basic and human imaging
research. The result is the Rutgers Training Program in Addiction Research (TARP), which aims to recruit a
diverse group of outstanding predoctoral and postdoctoral researchers and provide them with rigorous and
comprehensive training in interdisciplinary addiction-focused research. The goal is for all trainees to gain an
appreciation of addiction neuroscience research from cells to circuits to behavior. Our faculty members
represent an extraordinary range of addiction research expertise, from epigenetics to human imaging. The
thirteen participating mentors, who together hold over $10 million dollars in annual active research support,
have decades of collective experience training dozens of students and fellows who have gone on to successful
careers in academia, industry and government. More senior program mentors include Drs. Gary Aston-Jones,
Danielle Dick, Zhiping Pang and David Zald. The program director, Dr. Chris Pierce, initiated and co-directed a
NIDA-funded translational addiction training program (pre- and postdocs) for over nine years at the University
of Pennsylvania before he moved to Rutgers in early 2020. The proposed predoctoral and postdoctoral training
programs are integrated through events, programs and courses designed to foster interactions among trainees
as well as the Rutgers addiction research community as a whole. These joint activities satisfy many of the
goals of the program including practice communicating research findings, instruction in contemporary addiction
neuroscience research, grant writing, critiquing the addiction neuroscience research literature, networking,
leadership, career development, etc. All training activities also emphasize ethical conduct of research and the
importance of scientific rigor and reproducibility. Although the research and didactic aspects of the Rutgers
TARP are neuroscience focused (basic science and human imaging) we also strive to give our trainees a
better understanding of the totality of the field including the challenges associated with developing treatments
for substance use disorders. Our over-arching goal is to better equip the next generation of addiction
neuroscience researchers to apply novel and innovative approaches to develop new therapies, which are
needed now perhaps more than ever.
Public Health Relevance Statement
Project Narrative
The goal of the Rutgers Training Program in Addiction Research is to provide a diverse group of trainees with
an appreciation of modern interdisciplinary substance use disorder research, which could lay the groundwork
for the development of novel and innovative addiction treatments. The program encompasses a diverse array
of basic science approaches as well as human genetics and imaging studies. The didactic aspects of the
program take full advantage of the broad expertise of our faculty mentors while continually emphasizing
research ethics as well as training in scientific rigor and reproducibility.
No Sub Projects information available for 5T32DA055569-03
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5T32DA055569-03
Patents
No Patents information available for 5T32DA055569-03
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5T32DA055569-03
Clinical Studies
No Clinical Studies information available for 5T32DA055569-03
News and More
Related News Releases
No news release information available for 5T32DA055569-03
History
No Historical information available for 5T32DA055569-03
Similar Projects
No Similar Projects information available for 5T32DA055569-03